Time-dose response and mechanistic specificity of berberine in renal fibrosis from a multi-model integration perspective: a systematic review and meta-analysis on animal models
Abstract
Objective This research intends to comprehensively evaluate the efficacy of berberine (BBR) and the specificity of its mechanisms of action in different animal models of renal fibrosis through a multi-model integration strategy. Methods A comprehensive search of animal experimental studies was carried out across 10 different databases, including PubMed, Embase, Web of Science, Scopus, Cochrane Library, SCIELO, CNKI, Wanfang database, CBM and VIP Information Chinese Periodical Service Platform, spanning from their inception up to November 2024. The included studies’ methodological quality was assessed using the SYRCLE’s risk of bias tool for animal experiment, and statistical analyses were carried out with Stata 18.0. Results In total, 26 animal studies (2010–2024) were included, encompassing diverse models of renal fibrosis. The Meta-analysis revealed that BBR significantly lowered serum creatinine, blood urea nitrogen, α-SMA, and TGF-β1 levels, alongside reductions in renal fibrosis area and oxidative stress markers. The time-dose response analysis indicated that BBR was most efficacious within the 100–400 mg/kg dose range over a 5–12-week intervention period. Still, the mechanism of action was model-dependent: in the UUO model, BBR predominantly modulated the AMPK/PPARα pathway and ferroptosis, while in the DN model, it primarily targeted glycolipid metabolism and epigenetic regulation. Conclusion BBR significantly ameliorates renal fibrosis progression through a…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.